CELZ's logo.
Ticker Symbol: CELZ

Creative Medical Technology Holdings Inc

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001187953

Company Profile

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company committed to improving patient lives in the areas of Immunology, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings, Inc. is focused on regenerative medical solutions for unmet Immunological, Urological, Neurological and Orthopedic needs. The company has developed an extensive intellectual property portfolio utilizing stem cells and interrelated technologies for the treatment of multiple indications and commercialized complete patented and trademarked protocols for erectile dysfunction under the CaverStem® brand and the FemCelz® brand for the treatment of female sexual dysfunction. Its StemSpine® technology has undergone a pilot study and is prepared for commercialization of it’s autologous (patients own stem cells) program with the vision of progressing it’s patented allogenic (donor cells) program through FDA clinical trial. CELZ is also breaking new ground with its ImmCelz® technology for the treatment of multiple indications. Its team consists of leading physicians and scientists specializing in regenerative medicine. Its "science-first" approach to procedures ensures that all of its technology is proven to be both safe and effective.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags:
  • Miscellaneous

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $4.59
Change: -$0.22 ( -4.57%)
Days Range: $4.56 - $4.72
Beta: 0.23
52wk. High: $14.20
52wk. Low: $3.46
Ytd. Change 21.64%
50 Day Moving Average: $5.04
200 Day Moving Average: $5.39
Shares Outstanding: 14076238

Valuation

Market Cap: 6.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A